Noppadol Chanhom
Overview
Explore the profile of Noppadol Chanhom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chanhom N, Sonjan J, Inchai J, Udomsinprasert W, Chaikledkaew U, Suvichapanich S, et al.
Sci Rep
. 2024 Nov;
14(1):29511.
PMID: 39604537
Nevirapine (NVP) and Efavirenz (EFV) can cause antiretroviral drug-induced liver injury (ARVDILI). The objectives of this study were to summarize and analyze existing data on pharmacogenomics associated with nonnucleoside reverse...
2.
Udomsinprasert W, Jittikoon J, Chaikledkaew U, Saengsiwaritt W, Chanhom N, Suvichapanich S, et al.
Int J Infect Dis
. 2022 Aug;
122:1034-1040.
PMID: 35931370
Objectives: This study aimed to investigate whether mitochondrial DNA (mtDNA) content, an index of mitochondrial dysfunction, was associated with clinical parameters indicating anti-tuberculosis (TB) drug-induced liver injury (ATDILI) in TB...
3.
Chanhom N, Jittikoon J, Wattanapokayakit S, Mahasirimongkol S, Charoenyingwattana A, Udomsinprasert W, et al.
J Pers Med
. 2022 Jun;
12(6).
PMID: 35743726
Glutathione s-transferase (GST) is a family of drug-metabolizing enzymes responsible for metabolizing and detoxifying drugs and xenobiotic substances. Therefore, deletion polymorphisms of s can be implicated in developing several pathological...
4.
Chanhom N, Wattanapokayakit S, Satproedprai N, Suvichapanich S, Mahasirimongkol S, Chaikledkaew U, et al.
Heliyon
. 2021 May;
7(4):e06852.
PMID: 33981901
Antituberculosis drug-induced liver injury (ATDILI) is the common adverse reaction of antituberculosis drugs. Glutathione S-transferases (GSTs), which are phase II metabolizing enzymes for detoxification, are recognized as potential mediators of...
5.
Udomsinprasert W, Chanhom N, Suvichapanich S, Wattanapokayakit S, Mahasirimongkol S, Chantratita W, et al.
Sci Rep
. 2020 Mar;
10(1):5628.
PMID: 32221362
Despite being relatively rare, anti-tuberculosis drug-induced liver injury (ATDILI) is a leading cause of acute liver failure and a major reason for treatment discontinuation, because of no specific and selective...
6.
Chanhom N, Udomsinprasert W, Chaikledkaew U, Mahasirimongkol S, Wattanapokayakit S, Jittikoon J
Biomed Rep
. 2020 Mar;
12(4):153-162.
PMID: 32190303
Antituberculosis (anti-TB) drugs are the most common cause of drug-induced liver injury (DILI). There are numerous studies revealing the associations between the polymorphisms of pharmacogenes and the risk of anti-TB...
7.
Chumnumwat S, Lu Z, Sukasem C, Winther M, Capule F, Abdul Hamid A, et al.
Public Health Genomics
. 2019 Oct;
22(3-4):132-139.
PMID: 31587001
Pharmacogenomics (PGx) is increasingly being recognized as a potential tool for improving the efficacy and safety of drug therapy. Therefore, several efforts have been undertaken globally to facilitate the implementation...